Psychiatry - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 10 of 49
  • Item
    No Preview Available
    Associations between dairy consumption and constipation in adults: A cross-sectional study.
    Aslam, H ; Mohebbi, M ; Ruusunen, A ; Dawson, SL ; Williams, LJ ; Berk, M ; Holloway-Kew, KL ; Collier, F ; Loughman, A ; Pasco, JA ; Jacka, FN (SAGE Publications, 2022-03)
    OBJECTIVE: The current study aimed to assess the association between dairy consumption and constipation in the general adult population. DESIGN: Data from the Geelong Osteoporosis Study were used to assess the association between dairy consumption and constipation in women (n=632) and men (n=609). Information on milk, yogurt and cheese, and constipation were self-reported. Total dairy was calculated by summing the intake of milk, yogurt and cheese and expressed as servings per day. Multivariable logistic regression models adjusted for irritable bowel syndrome, major depressive disorders, mobility, body mass index, age and fibre intake were used to examine the odds ratio (OR) and 95% confidence interval (CI) between the consumption of categories of total dairy, milk, yogurt, cheese, and constipation. RESULTS: In women, consumption of 1-2 servings/d of total dairy was associated with reduced odds for constipation (OR: 0.49; 95% CI: 0.26-0.90; P=0.021) compared to consuming <1 serving/d of total dairy after adjusting for covariates. Also, consumption of 1-4 servings/d of milk was associated with marginally reduced odds for constipation (OR: 0.63; 95% CI: 0.39-1.02; P=0.058) compared to women who consumed <1 serving/d of milk after adjusting for covariates. There were no significant associations detected between other types of dairy consumption and constipation in women, and none in men. CONCLUSION: In women, consumption of moderate amounts of dairy is associated with reduced odds for constipation whereas in men no associations were detected between dairy consumption and constipation. Further studies are warranted to confirm results.
  • Item
    No Preview Available
    Comparison of the Accuracy of the 7-Item HADS Depression Subscale and 14-Item Total HADS for Screening for Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis
    Wu, Y ; Levis, B ; Daray, FM ; Ioannidis, JPA ; Patten, SB ; Cuijpers, P ; Ziegelstein, RC ; Gilbody, S ; Fischer, FH ; Fan, S ; Sun, Y ; He, C ; Krishnan, A ; Neupane, D ; Bhandari, PM ; Negeri, Z ; Riehm, KE ; Rice, DB ; Azar, M ; Yan, XW ; Imran, M ; Chiovitti, MJ ; Boruff, JT ; McMillan, D ; Kloda, LA ; Markham, S ; Henry, M ; Ismail, Z ; Loiselle, CG ; Mitchell, ND ; Al-Adawi, S ; Beck, KR ; Beraldi, A ; Bernstein, CN ; Boye, B ; Buel-Drabe, N ; Bunevicius, A ; Can, C ; Carter, G ; Chen, C-K ; Cheung, G ; Clover, K ; Conroy, RM ; Costa-Requena, G ; Cukor, D ; Dabscheck, E ; De Souza, J ; Downing, M ; Feinstein, A ; Ferentinos, PP ; Flint, AJ ; Gallagher, P ; Gandy, M ; Grassi, L ; Haerter, M ; Hernando, A ; Jackson, ML ; Jenewein, J ; Jette, N ; Juliao, M ; Kjaergaard, M ; Kohler, S ; Konig, H-H ; Krishna, LKR ; Lee, Y ; Loebner, M ; Loosman, WL ; Love, AW ; Loewe, B ; Malt, UF ; Marrie, RA ; Massardo, L ; Matsuoka, Y ; Mehnert, A ; Michopoulos, I ; Misery, L ; Nelson, CJ ; Ng, CG ; O'Donnell, ML ; O'Rourke, SJ ; Ozturk, A ; Pabst, A ; Pasco, JA ; Peceliuniene, J ; Pintor, L ; Ponsford, JL ; Pulido, F ; Quinn, TJ ; Reme, SE ; Reuter, K ; Riedel-Heller, SG ; Rooney, AG ; Sanchez-Gonzalez, R ; Saracino, RM ; Schellekens, MPJ ; Scherer, M ; Schwarzbold, ML ; Cankorur, VS ; Sharpe, L ; Sharpe, M ; Simard, S ; Singer, S ; Stafford, L ; Stone, J ; Strobe, NA ; Sultan, S ; Teixeira, AL ; Tiringer, I ; Turner, A ; Walker, J ; Walterfang, M ; Wang, L-J ; Weyerer, SB ; White, J ; Wiese, B ; Williams, LJ ; Wong, L-Y ; Benedetti, A ; Thombsi, BD (AMER PSYCHOLOGICAL ASSOC, 2023-02)
    The seven-item Hospital Anxiety and Depression Scale Depression subscale (HADS-D) and the total score of the 14-item HADS (HADS-T) are both used for major depression screening. Compared to the HADS-D, the HADS-T includes anxiety items and requires more time to complete. We compared the screening accuracy of the HADS-D and HADS-T for major depression detection. We conducted an individual participant data meta-analysis and fit bivariate random effects models to assess diagnostic accuracy among participants with both HADS-D and HADS-T scores. We identified optimal cutoffs, estimated sensitivity and specificity with 95% confidence intervals, and compared screening accuracy across paired cutoffs via two-stage and individual-level models. We used a 0.05 equivalence margin to assess equivalency in sensitivity and specificity. 20,700 participants (2,285 major depression cases) from 98 studies were included. Cutoffs of ≥7 for the HADS-D (sensitivity 0.79 [0.75, 0.83], specificity 0.78 [0.75, 0.80]) and ≥15 for the HADS-T (sensitivity 0.79 [0.76, 0.82], specificity 0.81 [0.78, 0.83]) minimized the distance to the top-left corner of the receiver operating characteristic curve. Across all sets of paired cutoffs evaluated, differences of sensitivity between HADS-T and HADS-D ranged from -0.05 to 0.01 (0.00 at paired optimal cutoffs), and differences of specificity were within 0.03 for all cutoffs (0.02-0.03). The pattern was similar among outpatients, although the HADS-T was slightly (not nonequivalently) more specific among inpatients. The accuracy of HADS-T was equivalent to the HADS-D for detecting major depression. In most settings, the shorter HADS-D would be preferred. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
  • Item
    No Preview Available
    Bipolar disorder and bone health: A case-control study
    Williams, LJ ; Stuart, AL ; Berk, M ; Brennan-Olsen, SL ; Hodge, JM ; Quirk, SE ; Koivumaa-Honkanen, H ; Honkanen, R ; Heikkinen, J ; Chandrasekaran, V ; Cleminson, JR ; Pasco, JA (ELSEVIER, 2022-07-01)
    BACKGROUND: Bipolar disorder (BD) is associated with significant psychological and physical comorbidity. Yet little is known about the bone health of individuals with BD. Thus, we aimed to investigate the association between BD and bone health in a population-based sample of women. METHODS: Women with a history of BD (cases; n = 117) were recruited from public and private health care settings and controls, without BD, were drawn from the Geelong Osteoporosis Study (n = 909). BD was identified using a semi-structured clinical interview (SCID-I/NP). Bone mineral density (BMD) was measured at the spine, femoral neck and total body using dual energy x-ray absorptiometry, and bone quality by quantitative heel ultrasound and included the following parameters: Speed of Sound (SOS), Broadband Ultrasound Attenuation (BUA) and Stiffness Index (SI). Weight and height were measured and information on medication use and lifestyle was obtained. RESULTS: Adjusted mean BMD among the cases was 4.3% lower at the hip and 1.6% lower at the total body compared to controls. Age was an effect modifier at the spine. Among women <50 years, mean spine BMD for cases was 3.5% lower than controls. No differences in spine BMD for those ≥50 years were detected. Cases also had a 1.0%, 3.2% and 7.8% lower adjusted mean SOS, BUA and SI compared to controls, respectively. LIMITATIONS: Course, chronicity and recovery of BD were not explored in relation to bone health. CONCLUSION: These data suggest BD is associated with low bone quantity and quality in women. Replication and research into underlying mechanisms is warranted.
  • Item
    Thumbnail Image
    Anticonvulsant use and fracture: a case-control study
    Chandrasekaran, V ; Stuart, AL ; Pasco, JA ; Brennan-Olsen, SL ; Berk, M ; Hodge, JM ; Samarasinghe, RM ; Williams, LJ (JMNI, 2021-09)
    OBJECTIVES: We aimed to investigate fracture risk associated with anticonvulsant use in a population-based sample of men and women. METHODS: Data from 1,458 participants (51.8% women) with a radiologically confirmed incident fracture (cases) were compared to 1,796 participants (46.5% women) without fracture (controls). Lifestyle factors, medication use and medical history were self-reported. Associations between anticonvulsant use and fracture were explored using binary logistic regression following adjustment for confounders. RESULTS: In men, fracture cases and controls differed in age, smoking history, education, alcohol use, and gonadal hormone supplementation. In women, fracture cases and controls differed by previous fracture history, alcohol use, physical activity levels and use of anti-fracture agents. After adjustment for age, pooled anticonvulsant use was associated with a 3.4-fold higher risk of fracture in men and a 1.8-fold higher risk in women. Following further adjustments for confounders these patterns persisted; a 2.8-fold higher fracture risk in men and a 1.8-fold higher fracture risk in women. CONCLUSIONS: Anticonvulsant use was associated with increased fracture risk, independent of demographic, lifestyle, medical and medication related factors. While further studies exploring potential underlying mechanisms are warranted, regular monitoring of bone health in anticonvulsant users with risk factors may be useful.
  • Item
    Thumbnail Image
    The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men
    Rauma, PH ; Pasco, JA ; Berk, M ; Stuart, AL ; Koivumaa-Honkanen, H ; Honkanen, RJ ; Hodge, JM ; Williams, LJ (JMNI, 2015-06)
    OBJECTIVE: Both depression and use of antidepressants have been negatively associated with bone mineral density (BMD) but mainly in studies among postmenopausal women. Therefore, the aim of this study was to investigate these relationships in men. METHODS: Between 2006 and 2011, 928 men (aged 24-98 years) from the Geelong Osteoporosis Study completed a comprehensive questionnaire, clinical measurements and had BMD assessments at the forearm, spine, total hip and total body. Major depressive disorder (MDD) was identified using a structured clinical interview (SCID-I/NP). The cross-sectional associations between BMD and both MDD and antidepressant use were analyzed using multivariable linear regression. RESULTS: Of the study population, 84 (9.1%) men had a single MDD episode, 50 (5.4%) had recurrent episodes and 65 (7.0%) were using antidepressants at the time of assessment. Following adjustments, recurrent MDD was associated with lower BMD at the forearm and total body (-6.5%, P=0.033 and -2.5%, P=0.033, respectively compared to men with no history of MDD), while single MDD episodes were associated with higher BMD at the total hip (+3.4%, P=0.030). Antidepressant use was associated with lower BMD only in lower-weight men (<75-110 kg depending on bone site). CONCLUSIONS: Both depression and use of antidepressants should be taken into account as possible risk factors for osteoporosis in men.
  • Item
    Thumbnail Image
    Falls in community-dwelling women with bipolar disorder: a case-control study
    Stuart, AL ; Pasco, JA ; Berk, M ; Quirk, SE ; Koivumaa-Honkanen, H ; Honkanen, R ; Mohebbi, M ; Williams, LJ (BMC, 2022-09-20)
    BACKGROUND: Falls are a common occurrence in psychiatric hospital settings, however population-based research among individuals with psychiatric disorders, in particular bipolar disorder (BD) is scant. Thus, we aimed to investigate falls risk in community-dwelling women diagnosed with BD. METHODS: Women with BD (cases, n = 119) were recruited from health care settings located in southeast Victoria, Australia. Age-matched controls (n = 357, ratio 3:1) without BD were participants in the Geelong Osteoporosis Study drawn from the same geographical region. Lifetime history of BD was identified by semi-structured clinical interview (SCID-IV/NP). Previous 12-month falls data were obtained via questionnaire. Information on mobility, alcohol use, general health, medication use, blood pressure, body mass index, socioeconomic status and use of a walking aid was collected. Generalised Estimating Equations, binary and ordinal logistic regression were used to determine the odds ratio (OR) and 95% confidence interval (CI) for falls following adjustment for confounders. RESULTS: During the 12-month period, 34 (28.6%, median age 48.4 yr) cases and 70 (19.6%, median age 49.1 yr) controls reported one fall; 22 (18.5%) cases and 18 (5.0%) controls reported ≥ two falls (p < 0.001). Cases had 2.5-fold increased odds of at least one fall and 2.9-fold increased likelihood of increasing falls categories (0 vs. 1 vs. 2 +), compared to controls [adjOR 2.5, 95%CI (1.8, 3.4), adjOR OR 2.9, 95%CI (2.0, 4.1)]. CONCLUSION: Risk of falls was greater among women with BD. Balance training could be a research and clinical focus for falls prevention programs among women with bipolar disorder to prevent the detrimental outcomes associated with falling.
  • Item
    Thumbnail Image
    The Role of Health Literacy in the Treatment of Osteoporosis
    Hosking, SM ; Buchbinder, R ; Pasco, JA ; Williams, LJ ; Brennan-Olsen, SL (WILEY, 2016-10)
  • Item
    Thumbnail Image
    The Microbiome: A Biological Mechanism Underpinning the Social Gradient of Musculoskeletal Conditions?
    Brennan-Olsen, SL ; Pasco, JA ; Williams, LJ ; Hyde, NK ; Jacka, FN (WILEY, 2016-06)
  • Item
    Thumbnail Image
    Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study
    Chandrasekaran, V ; Pasco, JA ; Stuart, AL ; Brennan-Olsen, SL ; Berk, M ; Hodge, JM ; Samarasinghe, RM ; Williams, LJ (BMC, 2021-02-11)
    BACKGROUND: Anticonvulsant use has been linked to bone deficits in specific patient populations. We studied the association between anticonvulsant use and bone health in a population-based sample of men and women. METHODS: Data from 926 men (24-73 yr) and 1070 women (21-94 yr) participating in the Geelong Osteoporosis Study were included. Bone mineral density (BMD, g/cm2) of the PA-spine and total hip was measured using dual-energy X-ray absorptiometry (Lunar). Bone quality was determined using quantitative heel ultrasound (QUS). Anthropometry was conducted and socioeconomic status was determined. Medication and lifestyle information was obtained via questionnaire. Linear regression was used to test associations between anticonvulsant use and bone health before and after adjustment for potential confounders. RESULTS: Seventeen (1.8%) men and 20 (1.9%) women reported anticonvulsant use. In men, anticonvulsant users had 9.1% lower adjusted mean BMD at the spine and hip compared to non-users. Body mass index was an effect modifier at the spine. Anticonvulsant users also had 1.8% lower speed of sound (SOS), 10.6% lower broadband ultrasound attenuation (BUA) and 13.7% lower stiffness index (SI) compared to non-users. In women, BMD tended to be lower at the hip compared to non-users as with the bone quality measure, BUA. No significant associations were observed at the spine or the other bone quality measures, SOS and SI. CONCLUSION: Our data suggest that bone quantity and quality, assessed using BMD and QUS, are lower for men and possibly women who use anticonvulsants. While further exploration into potential mechanisms is needed, our findings suggest that monitoring bone health among users of anticonvulsants is warranted.
  • Item
    Thumbnail Image
    Personality Disorder and Physical Health Comorbidities: A Link With Bone Health?
    Williams, LJ ; Quirk, SE ; Koivumaa-Honkanen, H ; Honkanen, R ; Pasco, JA ; Stuart, AL ; Kavanagh, BE ; Heikkinen, J ; Berk, M (FRONTIERS MEDIA SA, 2020-12-08)
    We examined whether personality disorders (PDs) (any, cluster A/B/C) were associated with bone mineral density (BMD) in a population-based sample of Australian women (n = 696). Personality and mood disorders were assessed using semi-structured diagnostic interviews. BMD was measured at the spine, hip, and total body using dual-energy x-ray absorptiometry (GE-Lunar Prodigy). Anthropometrics, medication use, physical conditions, and lifestyle factors were documented. The association between PDs (any, cluster A/B/C) and BMD (spine/hip/total body) was examined with multiple linear regression models. The best models were identified by backward elimination including age, weight, physical activity, smoking status, alcohol consumption, dietary calcium intake, mood disorders, physical multimorbidity, socioeconomic status, and medications affecting bone. The variables were retained in the model if p < 0.05. All potential interactions in final models were tested. Those with cluster A PD, compared to those without, had 6.7% lower hip BMD [age, weight adjusted mean 0.853 (95% CI 0.803-0.903) vs. 0.910 (95% CI 0.901-0.919) g/cm2, p = 0.027] and 3.4% lower total body BMD [age, weight, smoking, alcohol, calcium adjusted mean 1.102 (95% CI 1.064-1.140) vs. 1.139 (95% CI 1.128-1.150) g/cm2, p = 0.056]. No associations were observed between cluster B/C PDs and hip/total body BMD or between any of the PD clusters and spine BMD. To our knowledge, this study is the first to investigate the bone health of women with PD in a population-based sample. Given the paucity of literature, replication and longitudinal research including the examination of underlying mechanisms and sex differences are warranted.